Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.

Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer. Clin Lung Cancer. 2008 Sep; 9(5):285-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.